抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Sotrovimab
All
TD-VK565076_1.jpg
TD-VK565076_2.jpg
- Catalog： TD-VK565076
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： VIR-7831,GSK4182136,S309,CAS:2423014-07-5
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Sotrovimab
| Catalog No. | TD-VK565076 |
|---|---|
| Species reactivity | SARS-CoV-2 (2019-nCoV) |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG1, kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P0DTC2 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | VIR-7831,GSK4182136,S309,CAS:2423014-07-5 |
| Background | Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SDS-PAGE for Research Grade Sotrovimab. |
|
|
Detects RBD in indirect ELISAs. |